Infection precautions for SARS-CoV-2 in assisted reproduction centers – dodging an invisible bullet

Abstract The COVID-19 pandemic has forced many changes to how we interact in society, requiring that we protect ourselves and others from an invisible, airborne enemy called the SARS-CoV-2 virus. Until a vaccine is discovered and reaches high levels of distribution, everyone must continue to be diligent to limit viral spread. The practice of assisted reproduction during this pandemic presents unique challenges in addition to the risks that have been identified for general clinical care. The established good tissue practices employed in laboratories are not designed to protect gametes and embryos from an airborne virus, particularly one that may be shed by an asymptomatic staff member. Armed with theoretical risks, but lacking direct evidence, assisted reproduction teams must examine every aspect of their practice, identify areas at risk for exposure to the SARS-Cov-2 virus and develop a mitigation plan. Several professional fertility societies have created guidelines for best practices in patient care during the COVID-19 pandemic. As we learn more about SARS-CoV-2 updates have been issued to help adapt infection control and prevention protocols. This review discusses what is currently known about SARS-CoV-2 infection risks in assisted reproductive centers and recommends implementation of specific mitigation strategies.